Literature DB >> 8159360

Renal cell carcinoma in pregnancy: report of three cases and review of the literature.

D P Smith1, S M Goldman, D S Beggs, P J Lanigan.   

Abstract

BACKGROUND: Renal cell carcinoma is a potentially fatal tumor that occasionally presents during pregnancy. Based on our experience with three patients and a review of the recent cases in the literature, we believe there has been a change in presentation of this lesion over that described in previous reviews. CASES: Two of three women with renal cell carcinoma found during pregnancy had symptoms suggesting recurrent urinary tract infection. The renal tumors were all discovered by ultrasound. In addition, magnetic resonance imaging was used for preoperative, intragestational staging of one patient.
CONCLUSION: Renal cell carcinoma should be considered in women of childbearing age who present with recurrent or refractory urinary tract symptoms, flank pain, or a palpable flank mass. Ultrasound appears to be the imaging procedure of choice for evaluating the urinary system in pregnant women.

Entities:  

Mesh:

Year:  1994        PMID: 8159360

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  Renal cell carcinoma with inferior vena cava thrombus extending to the right atrium diagnosed during pregnancy.

Authors:  Efe C Ghanney; Jaime A Cavallo; Matthew A Levin; Ramachandra Reddy; Jeffrey Bander; Maria Mella; Joanne Stone; Myron Schwartz; Kenneth Haines; Umesh Gidwani; Reza Mehrazin
Journal:  Ther Adv Urol       Date:  2017-04-16

Review 2.  Renal cell carcinoma in pregnancy.

Authors:  M A Gladman; D MacDonald; J J Webster; T Cook; G Williams
Journal:  J R Soc Med       Date:  2002-04       Impact factor: 18.000

3.  A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion.

Authors:  László Mangel; Krisztina Bíró; István Battyáni; Péter Göcze; Tamás Tornóczky; Endre Kálmán
Journal:  BMC Cancer       Date:  2015-12-24       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.